News coverage about Healthequity (NASDAQ:HQY) has trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Healthequity earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave news headlines about the company an impact score of 44.9666939191942 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Several equities analysts have recently issued reports on the company. Chardan Capital upped their price target on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research note on Wednesday, December 6th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a research note on Wednesday, November 8th. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research note on Tuesday, November 7th. Cantor Fitzgerald reissued a “buy” rating and issued a $56.00 target price on shares of Healthequity in a research note on Monday, September 25th. Finally, Robert W. Baird reissued a “hold” rating on shares of Healthequity in a research note on Thursday, September 21st. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Healthequity presently has a consensus rating of “Buy” and a consensus price target of $58.33.
Healthequity (HQY) traded up $0.16 during trading hours on Tuesday, reaching $49.08. The company’s stock had a trading volume of 366,306 shares, compared to its average volume of 602,782. Healthequity has a 1 year low of $37.62 and a 1 year high of $55.31. The firm has a market capitalization of $2,980.00, a price-to-earnings ratio of 66.32, a price-to-earnings-growth ratio of 2.02 and a beta of 1.74.
In other Healthequity news, Director Frank Medici sold 7,900 shares of the stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $51.11, for a total value of $403,769.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Berkley Capital, Llc sold 373,500 shares of the stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $53.21, for a total value of $19,873,935.00. The disclosure for this sale can be found here. Insiders sold 1,116,434 shares of company stock worth $58,417,878 in the last three months. Insiders own 19.00% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Healthequity (HQY) Receiving Somewhat Positive News Coverage, Accern Reports” was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.com-unik.info/2018/01/16/healthequity-hqy-receiving-somewhat-positive-news-coverage-accern-reports.html.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.